Exactech Q2 Revenue $67.3 Million On Continuing Strong Extremities Revenue Post author:Sam Post published:July 27, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like AstraZeneca PLC Confirms CEO is Staying Put—For Now July 16, 2017 Intralytix Receives FDA Regulatory Clearance For Phage-Based Shigella Technology April 6, 2017 Ensysce Biosciences Inc. Attending NIH Conference: Cutting Edge Science Meeting Series To End The Opioid Crisis: Development Of Safe, Effective, Non-Addictive Pain Treatments June 11, 2017
Ensysce Biosciences Inc. Attending NIH Conference: Cutting Edge Science Meeting Series To End The Opioid Crisis: Development Of Safe, Effective, Non-Addictive Pain Treatments June 11, 2017